FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Terumo Corporation Stock AnalysisComprehensive stock analysis for Terumo Corporation (TRUMF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTRUMF
TRUMF
Terumo Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TRUMF
Home🔹Stocks🔹Terumo Corporation

Terumo Corporation

🇺🇸TRUMF•OTC

Terumo Corporation

🇺🇸TRUMF•OTC
Market cap
$18.89B
Sentiment

Your view on TRUMF

Mkt Cap
$18.89B
Sentiment
Your view
TRUMF
Terumo Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TRUMF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Terumo Corporation

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Hikaru Samejima
Headquarters
2-44-1, Hatagaya, Tokyo, JP
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Hikaru Samejima
Headquarters
2-44-1, Hatagaya, Tokyo, JP
Description

Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts.

The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V.

solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others.

The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others.

The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Terumo Corporation, and the rating behind it. TRUMF last traded at $12.80, 20.1× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Terumo Corporation. Starting points for Terumo Corporation: P/E 20.1, EPS $111.52, beta 0.24 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Terumo Corporation. Terumo Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Terumo Corporation. Trailing twelve-month EPS for Terumo Corporation stands at $111.52. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Terumo Corporation. Terumo Corporation has reported as a listed company since 2011. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Terumo Corporation valued side by side against its closest peers. Terumo Corporation is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Terumo Corporation, and how their positions are changing. At a $18.89B market value, institutional positions materially move Terumo Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Terumo Corporation executives and directors. Shares of Terumo Corporation have traded between $12.51 and $20.58 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Terumo Corporation. Terumo Corporation is a $18.89B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Terumo Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Terumo Corporation. Coverage tracks Terumo Corporation within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • CLPBF — Coloplast A/S
  • CLPBY — Coloplast A/S
  • KONEF — Wellbeing Digital Sciences Inc.
  • OCPNF — Olympus Corporation
  • ORINY — Orion Oyj
  • OTSKF — Otsuka Holdings Co., Ltd.
  • SAUHF — Straumann Holding AG
  • SAUHY — Straumann Holding AG

More Medical - Instruments & Supplies companies

  • SUVPF — Sartorius AG
  • SVSO — SheerVision, Inc.
  • TCGGY — Tecan Group AG
  • TCHBF — Tecan Group AG
  • TDVXF — Tobii Dynavox AB (publ)
  • TFX — Teleflex Incorporated
  • TGLVY — Top Glove Corporation Bhd.
  • TRJ.AX — Trajan Group Holdings Limited
  • TRUMY — Terumo Corporation
  • TSNLF — Tristel PLC
  • TUTH — Standard Dental Labs Inc.
  • UTMD — Utah Medical Products, Inc.

News

Latest Market News